Healthcare of Ontario Pension Plan Trust Fund Reduces Holdings in iShares Biotechnology ETF $IBB

Healthcare of Ontario Pension Plan Trust Fund trimmed its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 20.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 596,000 shares of the financial services provider’s stock after selling 154,000 shares during the period. Healthcare of Ontario Pension Plan Trust Fund’s holdings in iShares Biotechnology ETF were worth $100,587,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Dynamic Wealth Strategies LLC lifted its position in shares of iShares Biotechnology ETF by 16.6% in the 4th quarter. Dynamic Wealth Strategies LLC now owns 422 shares of the financial services provider’s stock worth $71,000 after purchasing an additional 60 shares during the period. Flagship Private Wealth LLC increased its stake in shares of iShares Biotechnology ETF by 2.0% in the 4th quarter. Flagship Private Wealth LLC now owns 3,084 shares of the financial services provider’s stock worth $521,000 after acquiring an additional 60 shares in the last quarter. Larson Financial Group LLC increased its stake in shares of iShares Biotechnology ETF by 2.3% in the 4th quarter. Larson Financial Group LLC now owns 2,717 shares of the financial services provider’s stock worth $458,000 after acquiring an additional 60 shares in the last quarter. Webster Bank N. A. increased its stake in shares of iShares Biotechnology ETF by 1.0% in the 4th quarter. Webster Bank N. A. now owns 6,476 shares of the financial services provider’s stock worth $1,093,000 after acquiring an additional 62 shares in the last quarter. Finally, Choreo LLC increased its stake in shares of iShares Biotechnology ETF by 2.2% in the 4th quarter. Choreo LLC now owns 3,043 shares of the financial services provider’s stock worth $514,000 after acquiring an additional 65 shares in the last quarter. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Up 0.1%

Shares of iShares Biotechnology ETF stock opened at $170.66 on Friday. The company has a 50-day moving average of $170.28 and a 200 day moving average of $170.65. iShares Biotechnology ETF has a 1 year low of $123.61 and a 1 year high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were paid a $0.1218 dividend. This represents a $0.49 annualized dividend and a dividend yield of 0.3%. The ex-dividend date was Tuesday, March 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.